O46.012 Antepartum hemorrhage with afibrinogenemia, second trimester

Name of the Condition

• Antepartum Hemorrhage with Afibrinogenemia, Second Trimester

Summary

Antepartum hemorrhage refers to bleeding from the genital tract during pregnancy, typically after 20 weeks of gestation. When associated with afibrinogenemia, the bleeding is exacerbated by a severe deficiency of fibrinogen, a critical protein in blood clotting. This condition can complicate management and increase risks to both the mother and fetus due to impaired clot formation.

Causes

Afibrinogenemia in antepartum hemorrhage may result from congenital deficiencies, acquired conditions (e.g., liver disease or severe infection), or complications like disseminated intravascular coagulation (DIC). Severe bleeding itself can deplete fibrinogen levels, creating a cycle of worsening coagulopathy.

Risk Factors

• Preexisting congenital fibrinogen deficiency
• Severe infection or sepsis
• Placental abruption or previa
• Trauma or abdominal injury
• Multiple pregnancies
• History of bleeding disorders or previous hemorrhage

Symptoms

• Vaginal bleeding (ranging from spotting to heavy flow)
• Excessive bruising or prolonged bleeding from minor injuries
• Fatigue or weakness (due to blood loss)
• Signs of coagulation issues, such as petechiae or uncontrolled bleeding

Diagnosis

Diagnosis involves assessing the bleeding pattern and evaluating coagulation status. Laboratory tests, including fibrinogen levels and clotting studies, confirm afibrinogenemia. Imaging (e.g., ultrasound) may identify obstetric causes of bleeding, while physical examination assesses maternal and fetal stability.

Treatment Options

Management focuses on stabilizing the mother and addressing the underlying cause. Interventions may include fibrinogen replacement therapy, blood transfusions, and obstetric measures to control bleeding. Close monitoring of maternal and fetal status is essential.

Prognosis and Follow-Up

Prognosis depends on the severity of bleeding, timely intervention, and underlying causes. Follow-up includes monitoring fibrinogen levels, assessing for recurrence, and evaluating fetal well-being. Long-term care may involve managing congenital deficiencies or addressing acquired conditions.

Complications

• Severe maternal hemorrhage or shock
• Fetal distress or loss
• Prolonged coagulopathy
• Complications from blood transfusions or treatments

Lifestyle & Prevention

• Avoid activities with high injury risk during pregnancy.
• Manage preexisting conditions (e.g., infections) promptly.
• Follow prenatal care guidelines to detect and address complications early.

When to Seek Professional Help

Seek immediate medical attention for heavy vaginal bleeding, signs of shock (e.g., dizziness, low blood pressure), or uncontrolled bleeding from injuries.

Tips for Medical Coders

Document the presence of afibrinogenemia and the trimester (second) clearly. Ensure coding aligns with clinical findings, and specify obstetric causes of hemorrhage when available. Verify that the code O46.012 is used only when afibrinogenemia is confirmed and the second trimester is documented.